A reassessment of mycophenolic acid as a lead compound for the development of inhibitors of chikungunya virus replication

Add time:07/11/2019    Source:sciencedirect.com

Mycophenolic acid (MPA) has been previously reported as an inhibitor of the chikugunya virus (CHIKV) with an EC50 value of 0.2 μM. We used MPA as a lead compound designing and synthesizing a series of isatins and benzolactones in a typical medicinal chemistry program. The synthesis and testing of 19 derivatives produced compounds with no desired activity which prompted us to retest the lead compound, MPA. We can reveal that MPA shows no anti-CHIKV activity and therefore needs to be reassessed as a lead compound for this target.

We also recommend Trading Suppliers and Manufacturers of 4,5-DIMETHOXY-2-TETRAZOL-1-YL-BENZOIC ACID (cas 462068-55-9). Pls Click Website Link as below: cas 462068-55-9 suppliers

Prev:Cinchona-derived thiourea catalyzed hydrophosphonylation of ketimines—an enantioselective synthesis of α-amino phosphonates
Next:Synthesis and structure–activity relationships of 6-{4-[(3-fluorobenzyl)oxy]phenoxy}nicotinamide derivatives as a novel class of NCX inhibitors: a QSAR study)